Production (Stage)
CareRx Corporation
CRRX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 158.20K | -1.60M | -263.90K | -1.01M | -383.50K |
| Total Depreciation and Amortization | 3.32M | 3.30M | 3.50M | 3.52M | 3.57M |
| Total Amortization of Deferred Charges | -- | 112.90K | -- | -- | -- |
| Total Other Non-Cash Items | 1.61M | 3.39M | 2.06M | 2.93M | 2.04M |
| Change in Net Operating Assets | 53.00K | 799.40K | 3.68M | 451.60K | 1.65M |
| Cash from Operations | 5.14M | 6.00M | 8.97M | 5.90M | 6.88M |
| Capital Expenditure | -1.15M | -1.93M | -878.40K | -740.30K | -502.90K |
| Sale of Property, Plant, and Equipment | -- | 3.60K | 18.30K | 104.50K | 17.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -110.80K | -542.20K | -431.10K | -375.60K | -493.20K |
| Cash from Investing | -1.26M | -2.47M | -1.29M | -1.01M | -979.10K |
| Total Debt Issued | 500.00K | 1.80M | -- | -- | -- |
| Total Debt Repaid | -2.74M | -4.64M | -7.62M | -7.67M | -3.45M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -246.00K | -331.00K | -224.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.24M | -1.22M | -1.30M | -2.94M | -166.00K |
| Cash from Financing | -2.43M | -3.08M | -6.78M | -7.92M | -2.69M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.45M | 455.80K | 899.60K | -3.03M | 3.22M |